(c) 2024 PillSync.com

24 HR Cyclobenzaprine hydrochloride 15 MG Extended Release Oral Capsule

1 INDICATIONS AND USAGE Cyclobenzaprine hydrochloride extended-release capsules are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion. Limitations of Use: Cyclobenzaprine hydrochloride extended-release capsules should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. Cyclobenzaprine hydrochloride extended-release capsules have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease or in children with cerebral palsy. Cyclobenzaprine hydrochloride extended-release capsules are a muscle relaxant indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. ( 1 ) Limitations of Use: Cyclobenzaprine hydrochloride extended-release capsules should be used only for short periods (up to 2 or 3 weeks) ( 1 ) Cyclobenzaprine hydrochloride extended-release capsules have not been found effective in the treatment of spasticity or cerebral palsy (1)

amneal pharmaceuticals of new york llc


3 years ago CAPSULE ORANGE B15 24 HR Cyclobenzaprine hydrochloride 15 MG Extended Release Oral Capsule

CAPSULE ORANGE B15

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

CYCLOBENZAPRINE HYDROCHLORIDE extended-release capsules are available in 15 mg and 30 mg strengths, packaged in bottles of 60 capsules.

CYCLOBENZAPRINE HYDROCHLORIDE Extended-Release capsules, 15 mg (NDC 0115-1436-13) are orange opaque body and orange opaque cap with "B15" in blue ink on cap.

CYCLOBENZAPRINE HYDROCHLORIDE Extended-Release capsules, 30 mg (NDC 0115-1437-13) are dark blue opaque body and standard red opaque cap with "B30" in white ink on cap. 16.2 Storage and Handling Dispense in a tight, light-resistant container as defined in the USP/NF. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].


More pills like CAPSULE B15

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site